📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

Preclinical efficacy of peanut-specific IgG4 antibody therapeutic IGNX001. (2024)

First Author: Croote D

Attributed to: MRC Transition Support CSF Alexandra Santos funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jaci.2024.07.014

PubMed Identifier: 39069172

Publication URI: http://europepmc.org/abstract/MED/39069172

Type: Journal Article/Review

Volume: 154

Parent Publication: The Journal of allergy and clinical immunology

Issue: 5

ISSN: 0091-6749